Evaluation of the virtues and pitfalls in an HIV screening algorithm based on two fourth generation assays - A step towards an improved national algorithm.

[1]  M. Battegay,et al.  Specificity of two HIV screening tests detecting simultaneously HIV-1 p24 antigen and antibodies to HIV-1 and -2. , 2017, Journal of virological methods.

[2]  Raynell Lang,et al.  HIV misdiagnosis: A root cause analysis leading to improvements in HIV diagnosis and patient care. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[3]  Á. Holguín,et al.  Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  J. Guarner.  Human immunodeficiency virus: Diagnostic approach. , 2017, Seminars in diagnostic pathology.

[5]  P. Peters,et al.  Real-world performance of the new US HIV testing algorithm in medical settings. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  M. Özdemir,et al.  Laboratory Algorithm in HIV Infection Diagnosis , 2016 .

[7]  T. Alexander.  Human Immunodeficiency Virus Diagnostic Testing: 30 Years of Evolution , 2016, Clinical and Vaccine Immunology.

[8]  O. Mor,et al.  Evaluation of Xpert HIV-1 Qual assay for resolution of HIV-1 infection in samples with negative or indeterminate Geenius HIV-1/2 results. , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  O. Mor,et al.  Evaluation of the Bio-Rad Geenius HIV 1/2 Assay as an Alternative to the INNO-LIA HIV 1/2 Assay for Confirmation of HIV Infection , 2014, Journal of Clinical Microbiology.

[10]  O. Tarasenko,et al.  2014 European Guideline on HIV testing , 2014, International journal of STD & AIDS.

[11]  M. Pentella,et al.  Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[12]  R. Coombs,et al.  Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  Timothy B Hallett,et al.  Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? , 2013, The Lancet.

[14]  W. Miller,et al.  The Detection and Management of Early HIV Infection: A Clinical and Public Health Emergency , 2013, Journal of acquired immune deficiency syndromes.

[15]  C. Sabin,et al.  Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study , 2012, Journal of the International AIDS Society.

[16]  P. Chavez,et al.  Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  C. Knussen,et al.  Reluctance to be tested for HIV , 2011 .

[18]  Sinyoung Kim,et al.  False-Positive Rate of a “Fourth-Generation” HIV Antigen/Antibody Combination Assay in an Area of Low HIV Prevalence , 2010, Clinical and Vaccine Immunology.

[19]  M. Kitahata.  When to start antiretroviral therapy. , 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[20]  K. Porter,et al.  Antiretroviral treatment of primary HIV infection to reduce onward transmission , 2010, Current opinion in HIV and AIDS.

[21]  S. Deeks,et al.  When to Start Antiretroviral Therapy , 2010, Current HIV/AIDS reports.

[22]  Atlanta,et al.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[23]  H. Doerr,et al.  Evaluation of a New Combined Antigen and Antibody Human Immunodeficiency Virus Screening Assay, VIDAS HIV DUO Ultra , 2002, Journal of Clinical Microbiology.

[24]  B. Branson,et al.  Vital signs: HIV prevention through care and treatment--United States. , 2011, MMWR. Morbidity and mortality weekly report.

[25]  J. Goedert,et al.  The new england journal of medicine Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival , 2009 .